1 in 4 Black men will be diagnosed with prostate cancer compared to 1 in 8 White men. Join us as we dissect how to tackle this disparity.
Breaking Down Barriers: Tackling Racial Inequities in Prostate Cancer
The racial disparity in prostate cancer is undeniable. Join us in October as we bring together a community of experts and allies to dive into the roots of the challenge and showcase some of the solutions that can really make a difference.
Event Details
Event Date
19 October 2023
Cost:
Free
Location:
Convene, 101 Park Avenue, New York, NY 10178
Event Host:
Prostate Cancer Research
Overview
1 in 4 Black men will be diagnosed with prostate cancer compared to 1 in 8 White men. Join us as we dissect how to tackle this disparity.
Topics being discussed as part of the health equity conference include:
- The scale of health disparities and how the field is changing
- Racial disparities in prostate cancer: how did we get here and how do we fix it?
- The structural and societal factors contributing to the racial disparity in prostate cancer
- Unraveling ancestry and harnessing immunity
- Demystifying and diversifying clinical trials
- Reducing barriers to screening and keeping therapies working
- How dedicated funding can make a difference
Join us as we examine and discuss the challenges and opportunities around health equity.
Event Schedule
The event schedule is subject to change.
09:15 a.m. - 10:00 a.m.
Registration and networking
10:00 a.m. - 10:15 a.m.
Welcoming address by Oliver Kemp, CEO, Prostate Cancer Research
“Leaving no man behind: Who we are and what we stand for”
10:15 a.m. - 10:30 a.m.
Showcasing Impact
“How our investment is making a difference”
10:30 a.m. - 11:15 a.m.
Opening keynote by Professor Clayton C Yates, Director for Translational Health Disparities and Global Health Equity Research, Johns Hopkins University
“The scale of health disparities and how the field is changing”
11:15 a.m. - 12:15 p.m.
Panel discussion
“Racial disparities in prostate cancer: how did we get here and how do we fix it?”
12:15 p.m. - 01:00 p.m.
Lunch
01:00 p.m. - 01:45 p.m.
Keynote: The structural and societal factors contributing to the racial disparity in prostate cancer
01:45 p.m. - 02:45 p.m.
Spotlight on PCR racial inequity projects part 1: Unravelling Ancestry and Harnessing Immunity
Dr Panagiotis Katsonis, Assistant Professor of Molecular and Human Genetics, Baylor College of Medicine, Dr Geou-Yarh (Stancy) Liou, Associate Professor, Clark Atlanta University, with Dr Naomi Elster, Director of Research, PCR
02:45 p.m. - 03:05 p.m.
How we are empowering people with prostate cancer
David James, Director of Patient Projects, PCR
03:05 p.m. - 03:30 p.m.
Break and networking
03:30 p.m. - 04:30 p.m.
Spotlight on PCR racial inequity projects part 2: Reducing Barriers to Screening and Keeping Therapies Working
Dr Hari Iyer, Assistant Professor at Rutgers Cancer Institute of New Jersey, Dr Xin Li, Senior Research Scientist at the Center for Cancer Research and Therapeutic Development, Clark Atlanta University, with Dr Naomi Elster, Director of Research, PCR
04:30 p.m. - 05:15 p.m.
Closing keynote – Alfred Samuels, PCR Patient Champion
My prostate cancer journey: how research saved my life
05:15 p.m. - 05:30 p.m.
Closing address by Oliver Kemp, CEO, PCR
Closing the gaps: the scale of our ambition in tackling health inequities
05:30 p.m. - 07:00 p.m.
Networking reception
With over 30 years’ experience of funding research into the diagnosis, treatment and care of prostate cancer, we are currently funding 23 projects at 19 institutions in both the UK and the US.
We are taking a variety of approaches that could benefit patients, such as making new discoveries about the biology of prostate cancer, improving current therapies, developing new treatments, improving access to treatment, and helping patients make better choices.
A key focus of our work is funding research into health equity as prostate cancer disproportionately affects the Black community in both the UK and the US in terms of higher diagnosis rates and worse outcomes, and we are excited to showcase the first phase of this work through the conference.
Thank you so much for supporting us as we work together to transform research and transform lives.